↓ Skip to main content

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment

Overview of attention for article published in Frontiers in Pharmacology, November 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
102 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment
Published in
Frontiers in Pharmacology, November 2018
DOI 10.3389/fphar.2018.01263
Pubmed ID
Authors

Krzysztof Piotr Malinowski, Paweł Kawalec, Wojciech Trabka, Christoph Sowada, Andrzej Pilc

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 102 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 13%
Student > Ph. D. Student 13 13%
Researcher 11 11%
Student > Master 10 10%
Other 9 9%
Other 6 6%
Unknown 40 39%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 18 18%
Medicine and Dentistry 13 13%
Social Sciences 5 5%
Economics, Econometrics and Finance 4 4%
Arts and Humanities 3 3%
Other 16 16%
Unknown 43 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2018.
All research outputs
#20,543,926
of 23,116,036 outputs
Outputs from Frontiers in Pharmacology
#10,346
of 16,477 outputs
Outputs of similar age
#300,468
of 344,946 outputs
Outputs of similar age from Frontiers in Pharmacology
#290
of 398 outputs
Altmetric has tracked 23,116,036 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,477 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,946 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 398 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.